Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib and Vinorelbine in Metastatic Breast Cancer
NCT00764972Phase 2Unknown
- Sponsor
- McGill University
- Start
- Oct 2007
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in breast cancer, sponsored by McGill University. Status: unknown.
02
Drugs
sorafenib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00764972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00764972.